Table 2.
Stage I | Stage II | Stage III | |
---|---|---|---|
BAFF (pg/mL) | 498.5 ± 187.0 | 813.7 ± 398.3 | 1365.4 ± 641.5 |
IL-6 (pg/mL) | 3.0 ± 1.2 | 6.2 ± 3.2 | 16.7 ± 8.5 |
IL-10 (pg/mL) | 126.1 ± 26.0 | 150.3 ± 29.6 | 232.1 ± 91.9 |
IL-15 (pg/mL) | 7.2 ± 1.2 | 7.7 ± 1.2 | 13.4 ± 6.4 |
CRR (mg/dL) | 0.6 ± 0.3 | 0.9 ± 0.6 | 1.2 ± 0.7 |
B2M (mg/L) | 1.8 ± 0.7 | 4.1 ± 3.5 | 7.4 ± 1.6 |
Ki-67 PI (%) | 4.0 ± 2.4 | 7.1 ± 5.2 | 16.5 ± 14.6 |
Infiltration (%) | 26.1 ± 10.8 | 39.4 ± 16.5 | 55.6 ± 14.6 |